01/26/2017 - 4:51pm

A new study from SPS Commerce based on responses from more than 500 retailers, suppliers and logistics firms worldwide, said that more than 35% of retailers are on track with their omnichannel execution, up nearly 200% year-over-year.

01/26/2017 - 4:19pm

If the Walgreens-Rite Aid deal is not extended, Walgreens may need to forfeit a $325 million termination fee, analysts noted.

01/26/2017 - 4:01pm

The April 4 event will examine how top brands are adopting new needs, motivations and practices within their organizations, and how best-practice companies are building stronger customer relationships through personalization, custom solutions and seamless omnichannel design.  

01/26/2017 - 12:39pm

After four decades in retailing, Panzer has been lucky enough to have a number of great mentors in business, but the Albertson’s healthcare chief tells DSN some of the most important lessons he ever learned came as a young cowhand on his grandmother’s Santa Fe ranch.

01/26/2017 - 10:03am

"At this time, we are actively engaged in discussion with Rite Aid regarding how to proceed," Walgreens Boots Alliance CEO Stefano Pessina told shareholders. "These discussions include taking into account anything that is required to gain approval."

01/26/2017 - 8:19am

McKesson reported revenues of $50.1 billion, up 5%, for the third quarter ended Dec. 31.

01/25/2017 - 2:12pm

A new TD Bank survey found 74% of retail executives saying they believe sales will increase in the next 12 months. 

01/25/2017 - 11:00am

The TD Bank-branded in-store ATM installation follows the company's expansion last summer in Boston-area Walgreens locations.

01/25/2017 - 10:41am

The New York Post late Tuesday night reported that neither Walgreens nor Rite Aid will the nix the deal if the they don't get regulatory approval by the deadline Jan. 27.  “I assume that is correct,” a source with direct knowledge of the situation told The Post on Tuesday. "Rite Aid’s shares closed up 5 cents, at $6.95, well below the offer price," The Post added. "Its shares could fall below $4 if the deal is blocked, sources said." (The New York Post)